Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	semaphorin receptor binding	SEMA4D SEMA3D SEMA3C	6.09e-05	23	67	3	GO:0030215
GeneOntologyMolecularFunction	chemorepellent activity	SEMA4D SEMA3D SEMA3C	1.24e-04	29	67	3	GO:0045499
GeneOntologyMolecularFunction	lysophosphatidic acid binding	VIL1 LPAR4	3.07e-04	8	67	2	GO:0035727
GeneOntologyBiologicalProcess	neural crest cell migration	SEMA4D SEMA3D SEMA3C GBX2	4.64e-05	62	66	4	GO:0001755
GeneOntologyBiologicalProcess	mesenchymal cell migration	SEMA4D SEMA3D SEMA3C GBX2	5.26e-05	64	66	4	GO:0090497
Domain	Semaphorin	SEMA4D SEMA3D SEMA3C	5.03e-05	20	68	3	IPR027231
Domain	Sema	SEMA4D SEMA3D SEMA3C	1.93e-04	31	68	3	SM00630
Domain	Semap_dom	SEMA4D SEMA3D SEMA3C	1.93e-04	31	68	3	IPR001627
Domain	Sema	SEMA4D SEMA3D SEMA3C	1.93e-04	31	68	3	PF01403
Domain	SEMA	SEMA4D SEMA3D SEMA3C	1.93e-04	31	68	3	PS51004
Domain	PSI	SEMA4D SEMA3D SEMA3C	5.49e-04	44	68	3	IPR016201
Domain	PSI	SEMA4D SEMA3D SEMA3C	6.26e-04	46	68	3	SM00423
Domain	Homeodomain-like	SETMAR TIGD1 GBX2 ZHX1 MYSM1 MYBL2	1.31e-03	332	68	6	IPR009057
Domain	RhoGAP	ARHGAP15 ARHGAP31 ARHGAP33	1.50e-03	62	68	3	SM00324
Domain	RhoGAP	ARHGAP15 ARHGAP31 ARHGAP33	1.57e-03	63	68	3	PF00620
Domain	RHOGAP	ARHGAP15 ARHGAP31 ARHGAP33	1.64e-03	64	68	3	PS50238
Domain	RhoGAP_dom	ARHGAP15 ARHGAP31 ARHGAP33	1.64e-03	64	68	3	IPR000198
Domain	-	ARHGAP15 ARHGAP31 ARHGAP33	1.64e-03	64	68	3	1.10.555.10
Domain	ZZ	ZZEF1 UTRN	1.92e-03	18	68	2	PF00569
Domain	NA_NEUROTRAN_SYMP_2	SLC6A3 SLC6A4	1.92e-03	18	68	2	PS00754
Domain	ZF_ZZ_2	ZZEF1 UTRN	1.92e-03	18	68	2	PS50135
Domain	ZF_ZZ_1	ZZEF1 UTRN	1.92e-03	18	68	2	PS01357
Domain	Znf_ZZ	ZZEF1 UTRN	2.15e-03	19	68	2	IPR000433
Domain	SNF	SLC6A3 SLC6A4	2.15e-03	19	68	2	PF00209
Domain	NA_NEUROTRAN_SYMP_1	SLC6A3 SLC6A4	2.15e-03	19	68	2	PS00610
Domain	NA_NEUROTRAN_SYMP_3	SLC6A3 SLC6A4	2.15e-03	19	68	2	PS50267
Domain	ZnF_ZZ	ZZEF1 UTRN	2.15e-03	19	68	2	SM00291
Domain	Na/ntran_symport	SLC6A3 SLC6A4	2.15e-03	19	68	2	IPR000175
Domain	-	PITPNM2 AHSA1	3.15e-03	23	68	2	3.30.530.20
Domain	START-like_dom	PITPNM2 AHSA1	3.15e-03	23	68	2	IPR023393
Domain	C2H2_Znf_fam	ZSCAN29 ZNF518A	3.42e-03	24	68	2	IPR027775
Domain	-	TIGD1 GBX2 ZHX1 MYSM1 MYBL2	3.69e-03	283	68	5	1.10.10.60
Domain	Rho_GTPase_activation_prot	ARHGAP15 ARHGAP31 ARHGAP33	4.06e-03	88	68	3	IPR008936
Domain	Spectrin_repeat	MCF2 UTRN	4.98e-03	29	68	2	IPR002017
Domain	PSI	SEMA4D SEMA3D	6.04e-03	32	68	2	PF01437
Domain	Spectrin/alpha-actinin	MCF2 UTRN	6.04e-03	32	68	2	IPR018159
Domain	Plexin_repeat	SEMA4D SEMA3D	6.04e-03	32	68	2	IPR002165
Domain	SPEC	MCF2 UTRN	6.04e-03	32	68	2	SM00150
Domain	Myb_DNA-binding	MYSM1 MYBL2	7.19e-03	35	68	2	PF00249
Domain	-	SEMA4D SEMA3D SEMA3C TULP4 NLE1	7.29e-03	333	68	5	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SEMA4D SEMA3D SEMA3C TULP4 NLE1	7.47e-03	335	68	5	IPR015943
Pubmed	Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice.	SLC6A3 SLC6A4	3.77e-06	2	68	2	19176817
Pubmed	Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea.	LMAN1 MBL2	3.77e-06	2	68	2	12175909
Pubmed	[VNTR polymorphisms of the serotonin transporter and dopamine transporter genes in male opiate addicts].	SLC6A3 SLC6A4	3.77e-06	2	68	2	12173460
Pubmed	Structural Insights into Arl1-Mediated Targeting of the Arf-GEF BIG1 to the trans-Golgi.	ARL1 ARFGEF1	3.77e-06	2	68	2	27373159
Pubmed	Treatment-resistant schizophrenia and DAT and SERT polymorphisms.	SLC6A3 SLC6A4	3.77e-06	2	68	2	24680725
Pubmed	Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.	SLC6A3 SLC6A4	3.77e-06	2	68	2	12630565
Pubmed	The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.	SLC6A3 SLC6A4	3.77e-06	2	68	2	17621383
Pubmed	A neurochemical approach to valuation sensitivity over gains and losses.	SLC6A3 SLC6A4	3.77e-06	2	68	2	19726478
Pubmed	Serotonergic neurons signal reward and punishment on multiple timescales.	SLC6A3 SLC6A4	3.77e-06	2	68	2	25714923
Pubmed	The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases.	LMAN1 MBL2	3.77e-06	2	68	2	15728497
Pubmed	Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.	SLC6A3 SLC6A4	3.77e-06	2	68	2	18588943
Pubmed	SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD).	SLC6A3 SLC6A4	3.77e-06	2	68	2	16139170
Pubmed	Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease.	SLC6A3 SLC6A4	3.77e-06	2	68	2	18973248
Pubmed	Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.	SLC6A3 SLC6A4	3.77e-06	2	68	2	11320258
Pubmed	Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1.	LMAN1 MBL2	3.77e-06	2	68	2	10725420
Pubmed	Polymorphisms in genes encoding the serotonin and dopamine pathways in two sisters with metachromatic leukodystrophy.	SLC6A3 SLC6A4	3.77e-06	2	68	2	18831910
Pubmed	Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics.	SLC6A3 SLC6A4	3.77e-06	2	68	2	20505557
Pubmed	5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attempts.	SLC6A3 SLC6A4	3.77e-06	2	68	2	12707931
Pubmed	Combined Simulation and Mutation Studies to Elucidate Selectivity of Unsubstituted Amphetamine-like Cathinones at the Dopamine Transporter.	SLC6A3 SLC6A4	3.77e-06	2	68	2	27860344
Pubmed	Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males.	SLC6A3 SLC6A4	3.77e-06	2	68	2	12658362
Pubmed	Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.	SLC6A3 SLC6A4	3.77e-06	2	68	2	22454241
Pubmed	Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding.	SLC6A3 SLC6A4	3.77e-06	2	68	2	34118233
Pubmed	Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins.	LMAN1 MBL2	3.77e-06	2	68	2	8267903
Pubmed	The genetic precursors and the advantageous and disadvantageous sequelae of inhibited temperament: an evolutionary perspective.	SLC6A3 SLC6A4	3.77e-06	2	68	2	23527493
Pubmed	Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.	SLC6A3 SLC6A4	3.77e-06	2	68	2	9636213
Pubmed	Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence.	SLC6A3 SLC6A4	3.77e-06	2	68	2	15148564
Pubmed	Mannose binding lectin polymorphisms as a disease-modulating factor in women with systemic lupus erythematosus from Canary Islands, Spain.	LMAN1 MBL2	3.77e-06	2	68	2	12672193
Pubmed	Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.	SLC6A3 SLC6A4	3.77e-06	2	68	2	27425420
Pubmed	No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese population.	SLC6A3 SLC6A4	3.77e-06	2	68	2	25019689
Pubmed	Circulating levels of mannose binding protein in human immunodeficiency virus infection.	LMAN1 MBL2	3.77e-06	2	68	2	8666845
Pubmed	An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects.	SLC6A3 SLC6A4	3.77e-06	2	68	2	16604301
Pubmed	Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism.	LMAN1 MBL2	3.77e-06	2	68	2	17496053
Pubmed	Imaging genetics for utility of risks over gains and losses.	SLC6A3 SLC6A4	3.77e-06	2	68	2	21801841
Pubmed	Relapse of drunk driving and association with traffic accidents, alcohol-related problems and biomarkers of impulsivity.	SLC6A3 NPSR1	3.77e-06	2	68	2	30472966
Pubmed	The synthesis of bivalent 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)-8-heterobicyclo[3.2.1]octanes as probes for proximal binding sites on the dopamine and serotonin transporters.	SLC6A3 SLC6A4	3.77e-06	2	68	2	18053732
Pubmed	Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome.	SLC6A3 SLC6A4	3.77e-06	2	68	2	20739786
Pubmed	Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.	SLC6A3 SLC6A4	3.77e-06	2	68	2	20644949
Pubmed	The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects.	SLC6A3 SLC6A4	3.77e-06	2	68	2	22138326
Pubmed	Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men.	SLC6A3 SLC6A4	3.77e-06	2	68	2	26984412
Pubmed	Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts.	SLC6A3 SLC6A4	3.77e-06	2	68	2	22006250
Pubmed	Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.	SLC6A3 SLC6A4	3.77e-06	2	68	2	24439516
Pubmed	A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo.	SLC6A3 SLC6A4 GBX2	4.77e-06	17	68	3	16339193
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	ARL1 SEMA3C LMAN1 DHCR24 ARFGEF1 ELP1 ZZEF1 MGA VDAC2	5.30e-06	657	68	9	36180527
Pubmed	Engrailed 1 shapes the dopaminergic and serotonergic landscape through proper isthmic organizer maintenance and function.	SLC6A3 SLC6A4 GBX2	5.71e-06	18	68	3	26879466
Pubmed	HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.	ARL1 INPP5D UTRN VDAC2	1.11e-05	70	68	4	17342744
Pubmed	Adolescent behavioral and neural reward sensitivity: a test of the differential susceptibility theory.	SLC6A3 SLC6A4	1.13e-05	3	68	2	27045841
Pubmed	Association of VNTR polymorphisms in DRD4, 5-HTT and DAT1 genes with obesity.	SLC6A3 SLC6A4	1.13e-05	3	68	2	25687785
Pubmed	SLC6A3 (DAT1) as a Novel Candidate Biomarker Gene for Suicidal Behavior.	SLC6A3 SLC6A4	1.13e-05	3	68	2	34199792
Pubmed	L-MBP is expressed in epithelial cells of mouse small intestine.	LMAN1 MBL2	1.13e-05	3	68	2	12471128
Pubmed	Differential susceptibility to maternal expressed emotion in children with ADHD and their siblings? Investigating plasticity genes, prosocial and antisocial behaviour.	SLC6A3 SLC6A4	1.13e-05	3	68	2	24929324
Pubmed	[Polymorphisms in Sleep and Cognitive Function Related Genes are Associated with Vehicle Crash History in Shift Working Bus Drivers].	SLC6A3 NPSR1	1.13e-05	3	68	2	30695550
Pubmed	Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.	LMAN1 MBL2	1.13e-05	3	68	2	12941144
Pubmed	Correlation of 5-HTT, BDNF and NPSR1 gene polymorphisms with anxiety and depression in asthmatic patients.	SLC6A4 NPSR1	1.13e-05	3	68	2	27176146
Pubmed	Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.	SLC6A3 SLC6A4	1.13e-05	3	68	2	12401330
Pubmed	Serotonin transporter role in identifying similarities between SIDS and idiopathic ALTE.	SLC6A3 SLC6A4	1.13e-05	3	68	2	22711722
Pubmed	Distinct neural mechanisms for the prosocial and rewarding properties of MDMA.	SLC6A3 SLC6A4	1.13e-05	3	68	2	31826983
Pubmed	Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder.	SLC6A3 SLC6A4	1.13e-05	3	68	2	19490304
Pubmed	Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?	SLC6A3 SLC6A4	1.13e-05	3	68	2	19767592
Pubmed	Search for association between suicide and 5-HTT, MAOA and DAT polymorphism in Polish males.	SLC6A3 SLC6A4	1.13e-05	3	68	2	21516943
Pubmed	Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF.	SLC6A3 SLC6A4	1.13e-05	3	68	2	21491204
Pubmed	Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.	VIL1 EGFR	1.13e-05	3	68	2	28953659
Pubmed	Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.	SLC6A3 SLC6A4	1.13e-05	3	68	2	19482066
Pubmed	The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.	SLC6A3 SLC6A4	1.13e-05	3	68	2	12177201
Pubmed	Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction.	SLC6A3 SLC6A4	1.13e-05	3	68	2	34516792
Pubmed	Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism.	SLC6A3 SLC6A4	1.13e-05	3	68	2	16125912
Pubmed	Changes in the methylation status of DAT, SERT, and MeCP2 gene promoters in the blood cell in families exposed to alcohol during the periconceptional period.	SLC6A3 SLC6A4	1.13e-05	3	68	2	25656446
Pubmed	Targeted gene expression in dopamine and serotonin neurons of the mouse brain.	SLC6A3 SLC6A4	1.13e-05	3	68	2	15763133
Pubmed	Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder.	SLC6A3 SLC6A4	1.13e-05	3	68	2	19906444
Pubmed	The association of monoamine-related gene polymorphisms with behavioural correlates of response inhibition: A meta-analytic review.	SLC6A3 SLC6A4	1.13e-05	3	68	2	29155230
Pubmed	Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans.	SLC6A3 SLC6A4	1.13e-05	3	68	2	22810728
Pubmed	Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits.	SLC6A3 SLC6A4	1.13e-05	3	68	2	17392738
Pubmed	A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder.	SLC6A3 SLC6A4	1.13e-05	3	68	2	21207241
Pubmed	Class 3 semaphorins expression and association with innervation and angiogenesis within the degenerate human intervertebral disc.	SEMA3D SEMA3C	1.13e-05	3	68	2	26286962
Pubmed	Aberrant accumulation of serotonin in dopaminergic neurons.	SLC6A3 SLC6A4	1.13e-05	3	68	2	16638624
Pubmed	PRC2-mediated repression is essential to maintain identity and function of differentiated dopaminergic and serotonergic neurons.	SLC6A3 SLC6A4	1.13e-05	3	68	2	36026451
Pubmed	A semaphorin code defines subpopulations of spinal motor neurons during mouse development.	SEMA4D SEMA3D SEMA3C	1.40e-05	24	68	3	15869472
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	SACS MGA AHSA1 UTRN	1.54e-05	76	68	4	27542412
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	ZSWIM8 FBH1 PNLIPRP2 MBL2 HKDC1 ODAD2 VDAC2	1.70e-05	415	68	7	16385451
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	LATS1 TULP4 ARHGAP31 PPFIBP2 INPP5D MGA ZHX1	2.13e-05	430	68	7	35044719
Pubmed	Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.	LMAN1 MBL2	2.25e-05	4	68	2	19380618
Pubmed	The genetic basis for smoking behavior: a systematic review and meta-analysis.	SLC6A3 SLC6A4	2.25e-05	4	68	2	15370155
Pubmed	Proteins that bind high-mannose sugars of the HIV envelope.	LMAN1 MBL2	2.25e-05	4	68	2	15572157
Pubmed	Personality endophenotypes for bipolar affective disorder: a family-based genetic association analysis.	SLC6A3 SLC6A4	2.25e-05	4	68	2	18826446
Pubmed	Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.	SLC6A3 SLC6A4	2.25e-05	4	68	2	17948872
Pubmed	The X-ray structure of human mannan-binding lectin-associated protein 19 (MAp19) and its interaction site with mannan-binding lectin and L-ficolin.	LMAN1 MBL2	2.25e-05	4	68	2	15117939
Pubmed	Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.	SLC6A3 SLC6A4	2.25e-05	4	68	2	11343649
Pubmed	[Study of genetic variants in the BDNF, COMT, DAT1 and SERT genes in Colombian children with attention deficit disorder].	SLC6A3 SLC6A4	2.25e-05	4	68	2	29122229
Pubmed	Testing for gene x environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior.	SLC6A3 SLC6A4	2.25e-05	4	68	2	17579368
Pubmed	Serotonin and Dopamine Candidate Gene Variants and Alcohol- and Non-Alcohol-Related Aggression.	SLC6A3 SLC6A4	2.25e-05	4	68	2	26041607
Pubmed	ADHD, CD, and ODD: Systematic review of genetic and environmental risk factors.	SLC6A3 SLC6A4	2.25e-05	4	68	2	29361339
Pubmed	Molecular genetic case-control women investigation from the first Brazilian high-risk study on functional psychosis.	SLC6A3 SLC6A4	2.25e-05	4	68	2	19142409
Pubmed	Genetics of Lesch's typology of alcoholism.	SLC6A3 SLC6A4	2.25e-05	4	68	2	17928119
Pubmed	Genetic influences on quantity of alcohol consumed by adolescents and young adults.	SLC6A3 SLC6A4	2.25e-05	4	68	2	15845322
Pubmed	Affect-modulated startle reflex and dopamine D4 receptor gene variation.	SLC6A3 SLC6A4	2.25e-05	4	68	2	19818050
Pubmed	Expression of Robo/Slit and Semaphorin/Plexin/Neuropilin family members in the developing hypothalamic paraventricular and supraoptic nuclei.	SEMA4D SEMA3D SEMA3C	2.26e-05	28	68	3	18617019
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	SEMA4D CADM1 LMAN1 EGFR LNPEP SLC20A1 CNP	3.60e-05	467	68	7	30194290
Pubmed	Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal.	SLC6A3 SLC6A4	3.75e-05	5	68	2	36202097
Pubmed	Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.	SLC6A3 SLC6A4	3.75e-05	5	68	2	17225991
Pubmed	High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1.	LMAN1 MBL2	3.75e-05	5	68	2	12487819
Pubmed	Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers.	SLC6A3 SLC6A4	3.75e-05	5	68	2	18197080
Cytoband	3q23	ATR NMNAT3	1.96e-03	44	68	2	3q23
Cytoband	Ensembl 112 genes in cytogenetic band chr10q22	ZSWIM8 HKDC1 VDAC2	3.70e-03	208	68	3	chr10q22
Cytoband	Ensembl 112 genes in cytogenetic band chr3q23	ATR NMNAT3	3.98e-03	63	68	2	chr3q23
Cytoband	2q37.1	INPP5D TIGD1	4.49e-03	67	68	2	2q37.1
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	INPP5D TIGD1 GBX2	4.66e-03	226	68	3	chr2q37
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA4D SEMA3D SEMA3C	2.33e-05	20	51	3	736
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP15 ARHGAP31 ARHGAP33	3.77e-04	50	51	3	721
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	ZZEF1 UTRN	1.16e-03	18	51	2	91
Coexpression	GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP	ZFAND1 CRACR2A ARHGAP15 INPP5D PRORP ZNF518A	1.11e-05	196	67	6	M8443
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	SACS SLC20A1 BCORL1 KCNAB2 MGA SENP5	1.24e-05	200	67	6	M9317
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	VIL1 LPAR4 ATR TULP4 SACS DHCR24 MBL2 MGA UTRN MYSM1 ZNF518A	2.54e-05	778	66	11	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	SEMA3D LPAR4 ARHGAP31 DHCR24 BCORL1 UTRN MYSM1	2.64e-05	281	66	7	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	SEMA3D LMAN1 LPAR4 TULP4 ARHGAP31 DHCR24 BCORL1 LSP1 MGA UTRN MYSM1	2.92e-05	790	66	11	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	VIL1 LPAR4 TULP4 DHCR24 MBL2 MCF2 MGA MYSM1 ZNF518A MYBL2	1.25e-04	770	66	10	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	SEMA3D LATS1 LPAR4 ARHGAP15 TULP4 EGFR CMTR2 ZNF518A	1.39e-04	492	66	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274	SEMA3D LATS1 TULP4 LNPEP CMTR2 ZNF518A	1.44e-04	256	66	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	SEMA3D LMAN1 LPAR4 ARHGAP31 DHCR24 BCORL1 LSP1 MGA UTRN MYSM1	1.68e-04	799	66	10	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	SEMA3D LMAN1 LPAR4 TULP4 ARHGAP31 DHCR24 BCORL1 MGA UTRN MYSM1	1.72e-04	801	66	10	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	LPAR4 DHCR24 BCORL1 LSP1 MGA UTRN MYSM1	2.54e-04	404	66	7	gudmap_developingGonad_e18.5_epididymis_500
ToppCell	background-NK_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	SEMA4D ARHGAP15 LNPEP INPP5D LSP1 UTRN	5.06e-07	193	68	6	f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SEMA3D ARHGAP15 ARHGAP31 PPFIBP2 HKDC1	3.86e-06	154	68	5	d22902d2922784583f7016453768ed05b14b965e
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4D ARHGAP15 SACS LNPEP LSP1	4.65e-06	160	68	5	8dae9b0cf90a09acb196223f45a14680102630b2
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	CRACR2A SLC20A1 BCORL1 KCNAB2 HKDC1	8.24e-06	180	68	5	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRACR2A ARHGAP15 INPP5D KCNAB2 LSP1	1.07e-05	190	68	5	ba61f04fd38efae01f721ba616252d1372ff1002
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRACR2A ARHGAP15 INPP5D KCNAB2 LSP1	1.07e-05	190	68	5	5a37568000dfc33fcbb59b578c1963fb7cf872ec
ToppCell	Fetal_29-31_weeks-Immune\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA4D ARHGAP15 INPP5D KCNAB2 LSP1	1.31e-05	198	68	5	5dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	KIAA0408 SEMA3D SEMA3C LPAR4 EGFR	1.31e-05	198	68	5	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D CRACR2A ARHGAP15 INPP5D KCNAB2	1.37e-05	200	68	5	9ef322486e46e4ff05a8cbe06cf8019e996c94b3
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4D ARHGAP15 LSP1 MYSM1	7.98e-05	149	68	4	48fca6ae33d7722c024b43ce04f4dbce7b6b424b
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ZFAND1 MGA ZHX1 MYSM1	8.84e-05	153	68	4	553dff9688a1996d8f4ba16e60c683593d781389
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ZFAND1 MGA ZHX1 MYSM1	8.84e-05	153	68	4	88ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP15 KCNAB2 LSP1 MYBL2	9.77e-05	157	68	4	eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4D ARHGAP15 LNPEP LSP1	1.00e-04	158	68	4	90ca742739a208d457db087655ba3d1c18a9da57
ToppCell	droplet-Heart-nan-24m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 ZSWIM8 PPFIBP2 CMTR2	1.03e-04	159	68	4	7ad3a91d29639b32f6264c91f401c14a35469ac0
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC6A4 INPP5D DHCR24 PADI1	1.05e-04	160	68	4	5d22c86deead516444349d495998e04586be4396
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Mast\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC6A4 INPP5D DHCR24 PADI1	1.05e-04	160	68	4	ca212634cf1875238071d1800ecdf34979a553fb
ToppCell	Fetal_29-31_weeks-Immune-mast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA4D ARHGAP15 INPP5D NMNAT3	1.13e-04	163	68	4	03b2ec226adffba3ce893f3d12e549c841e662fd
ToppCell	droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSP1 CNP ARHGAP33 PADI1	1.24e-04	167	68	4	1248f809afbcccb42ce9e29cfe6fa1f6f6b65005
ToppCell	droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSP1 CNP ARHGAP33 PADI1	1.24e-04	167	68	4	a66552667aa6e8992c159df27a57c2e8ae14a9ce
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	SEMA3C CADM1 ARHGAP31 CNP	1.27e-04	168	68	4	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP15 LSP1 CMTR2 CNP	1.33e-04	170	68	4	6210ee3bf29059e6149c047bb7e02c5f59441519
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CADM1 EGFR DHCR24 UTRN	1.42e-04	173	68	4	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP15 INPP5D KCNAB2 LSP1	1.42e-04	173	68	4	0a0127bcb1d7b2b6125faef576dd843055095528
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SEMA4D CRACR2A ARHGAP15 INPP5D	1.45e-04	174	68	4	33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CADM1 FBH1 LMAN1 MYBL2	1.48e-04	175	68	4	3b5346fba617292de71963b6175e85a4f182fe30
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	FBH1 DHCR24 ELP1 UTRN	1.52e-04	176	68	4	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA4D INPP5D KCNAB2 UTRN	1.52e-04	176	68	4	6b06da40eb97ea2db09f3a769494738b3e5fe3fa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D EGFR UTRN NMNAT3	1.52e-04	176	68	4	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D EGFR UTRN NMNAT3	1.55e-04	177	68	4	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	facs-Liver-Non-hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4D ARHGAP31 INPP5D LSP1	1.55e-04	177	68	4	f73ed860685a724591d0f543a9ac4e868aff92f5
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARHGAP15 SLC20A1 INPP5D LSP1	1.55e-04	177	68	4	c5e829bc4594761666d65cace5a9c5d19c16f187
ToppCell	Control-Lymphocytic_NKT-T_cells-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA4D ARHGAP15 KCNAB2 LSP1	1.58e-04	178	68	4	910f8bea19d335455aba24e6a07b4834b709db5d
ToppCell	Control-Lymphocytic_NKT-T_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA4D ARHGAP15 KCNAB2 LSP1	1.62e-04	179	68	4	d892d9496f1c33e23312092591eb2e968e736f7d
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM1 EGFR CNP PADI1	1.65e-04	180	68	4	64f01494a4052186773720e10b4e7c724ff94547
ToppCell	Adult-Immune-natural_killer_cell-D175\|Adult / Lineage, Cell type, age group and donor	SEMA4D CRACR2A ARHGAP15 INPP5D	1.65e-04	180	68	4	fc59e28f39e7d4fb1bcc7205202cf39224b70d7b
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-B_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP15 INPP5D LSP1 CNP	1.65e-04	180	68	4	14ca8875af7cceead88fec147a4c0ef4d5a41f26
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D EGFR UTRN NMNAT3	1.69e-04	181	68	4	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	facs-Trachea-18m-Hematologic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA4D ARHGAP15 INPP5D LSP1	1.72e-04	182	68	4	a72b200488d212f1783233a94fc9a9596269f284
ToppCell	RA-17._Lymphocyte\|RA / Chamber and Cluster_Paper	SEMA4D ARHGAP15 INPP5D KCNAB2	1.72e-04	182	68	4	257a7847917b6ea1d60608183d90300bfd028758
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A4 SEMA3C CADM1 CNP	1.76e-04	183	68	4	876b4f128c2168fdae7488201ff44f19c06c8415
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A4 SEMA3C CADM1 CNP	1.76e-04	183	68	4	b190b650e61b1b20baf5e42d04acac82d3fd1400
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP15 INPP5D LSP1 CNP	1.76e-04	183	68	4	56038766980a4186ecd3b4a327a91c12979d2364
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Lymphocytic\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP15 INPP5D LSP1 CNP	1.76e-04	183	68	4	eb2f37c3d6d0502fb9eb512537fc2a002a1b92ed
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4D SEMA3C CADM1 CNP	1.76e-04	183	68	4	8330c39184ce076e1f95fd3725b68af551d89db0
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A4 CADM1 DHCR24 CNP	1.87e-04	186	68	4	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	LNPEP SLC20A1 ARFGEF1 UTRN	1.95e-04	188	68	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA3C LATS1 ARHGAP31 PPFIBP2	1.95e-04	188	68	4	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA3C LATS1 ARHGAP31 PPFIBP2	1.95e-04	188	68	4	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA3C LATS1 ARHGAP31 PPFIBP2	1.95e-04	188	68	4	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D EGFR UTRN NMNAT3	1.95e-04	188	68	4	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	background-B_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ARHGAP15 INPP5D LSP1 MYBL2	1.95e-04	188	68	4	9acb7a95e3095f15918a5d094107d1d565a42842
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP15 LNPEP INPP5D UTRN	2.03e-04	190	68	4	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC6A3 DHCR24 ARHGAP33 MYBL2	2.03e-04	190	68	4	c3c65d1f24e0ebdbb9adb617bed299a668f423f5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CADM1 LMAN1 LPAR4 MYBL2	2.03e-04	190	68	4	f85cdd79eefd699ada7a91bf4997cc730a9b9846
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA4D ARHGAP15 INPP5D KCNAB2	2.07e-04	191	68	4	5696e2e2db7b898a1c7ab3582ae74cb712dd5bdf
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP15 INPP5D KCNAB2 LSP1	2.07e-04	191	68	4	c72e62cf5b45c04ee5e7719db31f917c4f76b1e4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CADM1 LMAN1 LPAR4 MYBL2	2.11e-04	192	68	4	ec279980602292fc8ed6362edd36a5c772d59777
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PITPNM2 ARHGAP31 INPP5D UTRN	2.11e-04	192	68	4	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP15 INPP5D KCNAB2 LSP1	2.11e-04	192	68	4	b498618505bb1b7ff9574d06875dd272c11bac39
ToppCell	NS-moderate-d_07-13-Lymphoid\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SEMA4D ARHGAP15 INPP5D LSP1	2.11e-04	192	68	4	bd4059bfc2159f5ed8bbb2a5408b56117ca6f8e1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.11e-04	192	68	4	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARL1 CADM1 LMAN1 MYBL2	2.16e-04	193	68	4	1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	LATS1 ATR MGA UTRN	2.16e-04	193	68	4	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ATXN7L3 FBH1 ATR DHCR24	2.16e-04	193	68	4	0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARL1 CADM1 LMAN1 MYBL2	2.16e-04	193	68	4	b9c00df1b216eaa4283315713f1c9ef552d3d435
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARHGAP15 INPP5D KCNAB2 UTRN	2.20e-04	194	68	4	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARHGAP15 INPP5D KCNAB2 UTRN	2.20e-04	194	68	4	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	COVID-19-lung-NK_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SEMA4D ARHGAP15 INPP5D KCNAB2	2.20e-04	194	68	4	4c92f18e0a34fb50630d4b260eaf179202508b6d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.29e-04	196	68	4	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	SEMA3D ARHGAP31 INPP5D UTRN	2.29e-04	196	68	4	ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.29e-04	196	68	4	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.29e-04	196	68	4	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.29e-04	196	68	4	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	5'-Adult-Appendix-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA4D ARHGAP15 INPP5D LSP1	2.29e-04	196	68	4	3f065139f76ed048875cd6c03aa02300db2b6574
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA4D CADM1 EGFR NMNAT3	2.29e-04	196	68	4	1bcae4e0a244af822e2b12b2026a2771316f107d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.29e-04	196	68	4	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP15 INPP5D KCNAB2 LSP1	2.33e-04	197	68	4	363ae03310f63a586ba3cea2a59f35d5a335a54e
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SLC6A4 LNPEP MCF2 UTRN	2.38e-04	198	68	4	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.38e-04	198	68	4	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.38e-04	198	68	4	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZSCAN29 SEMA3C CRACR2A PLEKHA6	2.38e-04	198	68	4	1fe60443c11d34b6d2671af8f06e0dedc8d1558b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D ARHGAP31 INPP5D UTRN	2.38e-04	198	68	4	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D KCNAB2	2.42e-04	199	68	4	bc93e5c36ab60b66fb633c954b05d4dc09a7f152
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D KCNAB2	2.42e-04	199	68	4	6150b272313d3fbf5ddcb3a8d51862d368220fe2
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP15 INPP5D KCNAB2 PRORP	2.42e-04	199	68	4	7d69785717073491b5fb81bf24db0175f86cd0b0
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP15 INPP5D KCNAB2 LSP1	2.42e-04	199	68	4	ac866ae110967c5867ff4601939b79861d43df54
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D KCNAB2	2.47e-04	200	68	4	d8459e45a8396a9ee063666a1928c649162c5727
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP15 INPP5D KCNAB2 LSP1	2.47e-04	200	68	4	fd72fe6565e2f4885481991492d58c323ab1ad40
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	KIAA0408 SEMA3D SEMA3C NMNAT3	2.47e-04	200	68	4	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	KIAA0408 SEMA3D PLEKHA6 NMNAT3	2.47e-04	200	68	4	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D LSP1	2.47e-04	200	68	4	7eed3d932018d6a87ce37d013883b371db55caeb
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	KIAA0408 SEMA3D SEMA3C NMNAT3	2.47e-04	200	68	4	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIAA0408 SEMA3D SEMA3C NMNAT3	2.47e-04	200	68	4	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KIAA0408 SEMA3C CADM1 NMNAT3	2.47e-04	200	68	4	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIAA0408 SEMA3D SEMA3C NMNAT3	2.47e-04	200	68	4	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D LSP1	2.47e-04	200	68	4	56d738ff019682af7f1f8cbe7b262a75dc8596d5
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D KCNAB2	2.47e-04	200	68	4	8474e5d031d25bfb8461d39fa2053da01a6304fc
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D CRACR2A ARHGAP15 INPP5D	2.47e-04	200	68	4	1779a8ff4443a85ac500f849764e86d9c7529b84
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA4D ARHGAP15 INPP5D LSP1	2.47e-04	200	68	4	0f8e2fed93cc103b20a825d8d3e83787c5c015cc
Computational	Genes in the cancer module 218.	SLC6A3 SLC6A4 SLC20A1	5.61e-05	20	41	3	MODULE_218
Drug	N-Nor-cit	SLC6A3 SLC6A4	8.79e-06	2	68	2	CID000131993
Drug	dichloropane	SLC6A3 SLC6A4	8.79e-06	2	68	2	CID000127024
Drug	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	SLC6A3 SLC6A4	8.79e-06	2	68	2	ctd:C069723
Drug	Sertraline	SLC6A3 SLC6A4	8.79e-06	2	68	2	DB01104
Drug	benzhydryl ether	SLC6A3 SLC6A4	8.79e-06	2	68	2	CID000011323
Drug	methylcyanoformate	SLC6A3 SLC6A4	8.79e-06	2	68	2	CID000028660
Drug	NU1025; Up 200; 100uM; MCF7; HG-U133A	SLC6A4 LMAN1 ATR FBXO42 CPSF1 UTRN	2.50e-05	194	68	6	608_UP
Drug	D-161 compound	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C532102
Drug	Mazindol	SLC6A3 SLC6A4	2.63e-05	3	68	2	DB00579
Drug	Dexmethylphenidate	SLC6A3 SLC6A4	2.63e-05	3	68	2	DB06701
Drug	Methylphenidate	SLC6A3 SLC6A4	2.63e-05	3	68	2	DB00422
Drug	Duloxetine	SLC6A3 SLC6A4	2.63e-05	3	68	2	DB00476
Drug	2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C569113
Drug	Venlafaxine	SLC6A3 SLC6A4	2.63e-05	3	68	2	DB00285
Drug	2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C000595926
Drug	4-fluoroamphetamine	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C040639
Drug	1,4-diazabicyclo[3.3.1]nonane	SLC6A3 SLC6A4	2.63e-05	3	68	2	CID015140257
Drug	99mTc-NC100697	SLC6A3 SLC6A4	2.63e-05	3	68	2	CID016066474
Drug	Sibutramine	SLC6A3 SLC6A4	2.63e-05	3	68	2	DB01105
Drug	RTI-219	SLC6A3 SLC6A4	2.63e-05	3	68	2	CID010524711
Drug	2-(4-bromo-2,5-dimethoxyphenyl)ethylamine	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C079321
Drug	5-(2-aminopropyl)benzofuran	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C000608250
Drug	1-phenyl-2-(1-pyrrolidinyl)-1-pentanone	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C000592273
Drug	4-methoxymethamphetamine	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C060169
Drug	difluoropine	SLC6A3 SLC6A4	2.63e-05	3	68	2	CID000190851
Drug	2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine	SLC6A3 SLC6A4	2.63e-05	3	68	2	ctd:C554181
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	SEMA4D EGFR FBXO42 BCORL1 ELP1 SENP5	2.72e-05	197	68	6	2796_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A	SEMA4D SEMA3D LMAN1 LPAR4 KCNAB2 ARHGAP33	2.72e-05	197	68	6	6335_UP
Drug	4-(4-Chlorophenyl)piperidine	SLC6A3 SLC6A4	5.25e-05	4	68	2	CID001203613
Drug	Fluorescent Dyes	SLC6A3 SLC6A4	5.25e-05	4	68	2	ctd:D005456
Drug	butriptyline	SLC6A3 SLC6A4	5.25e-05	4	68	2	CID000021771
Drug	Chlorpheniramine	SLC6A3 SLC6A4	5.25e-05	4	68	2	DB01114
Drug	bicyclo[3.2.1]octane	SLC6A3 SLC6A4	5.25e-05	4	68	2	CID000260716
Drug	benzylpiperidine	SLC6A3 SLC6A4	5.25e-05	4	68	2	CID000076190
Drug	O 526	SLC6A3 SLC6A4	5.25e-05	4	68	2	CID003025846
Drug	indatraline	SLC6A3 SLC6A4	5.25e-05	4	68	2	ctd:C418119
Drug	Biogenic Monoamines	SLC6A3 SLC6A4	5.25e-05	4	68	2	ctd:D015306
Drug	anthocyanin	SLC20A1 TIGD1 MYSM1 MYBL2	5.75e-05	70	68	4	CID000145857
Drug	vinyl sulfoxide	SLC6A3 SLC6A4	8.74e-05	5	68	2	CID000014217
Drug	Phentermine	SLC6A3 SLC6A4	8.74e-05	5	68	2	DB00191
Drug	[11c]afa	SLC6A3 SLC6A4	8.74e-05	5	68	2	CID005352128
Drug	[11c]afm	SLC6A3 SLC6A4	8.74e-05	5	68	2	CID005352125
Drug	Mazindol	SLC6A3 SLC6A4	8.74e-05	5	68	2	ctd:D008454
Drug	[11c]afe	SLC6A3 SLC6A4	8.74e-05	5	68	2	CID005732447
Drug	Nomifensine	SLC6A3 SLC6A4	8.74e-05	5	68	2	ctd:D009627
Drug	AC1L9NDJ	SLC6A3 SLC6A4	1.31e-04	6	68	2	CID000449667
Drug	Escitalopram	SLC6A3 SLC6A4	1.31e-04	6	68	2	DB01175
Drug	naphthalene-1,5-disulfonate	SLC6A3 SLC6A4	1.31e-04	6	68	2	CID000006666
Drug	3 MMA	SLC6A3 SLC6A4	1.31e-04	6	68	2	CID000130136
Drug	Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; HL60; HT_HG-U133A	CADM1 LMAN1 SACS DHCR24 KCNAB2	1.36e-04	165	68	5	2145_DN
Drug	3'-dCTP	DHCR24 ARFGEF1 ACYP2 UTRN	1.53e-04	90	68	4	CID000153054
Drug	3,4-Methylenedioxymethamphetamine	SLC6A3 SLC6A4	1.83e-04	7	68	2	DB01454
Drug	MMDA	SLC6A3 SLC6A4	1.83e-04	7	68	2	DB01442
Drug	4-Methoxyamphetamine	SLC6A3 SLC6A4	1.83e-04	7	68	2	DB01472
Drug	NSC-274275	SLC6A3 SLC6A4	1.83e-04	7	68	2	CID000321672
Drug	Pseudoephedrine	SLC6A3 SLC6A4	1.83e-04	7	68	2	DB00852
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A	ARL1 SACS DHCR24 FBXO42 SENP5	2.31e-04	185	68	5	2927_DN
Drug	RTI-121	SLC6A3 SLC6A4	2.43e-04	8	68	2	CID000122190
Drug	AC1L1GIZ	SLC6A3 SLC6A4	2.43e-04	8	68	2	CID000003703
Drug	Cocaine	SLC6A3 SLC6A4	2.43e-04	8	68	2	DB00907
Drug	4-nitrotoluene	SLC6A3 EGFR	2.43e-04	8	68	2	ctd:C017572
Drug	6-fluorotryptamine	SLC6A3 SLC6A4	2.43e-04	8	68	2	CID000854024
Drug	Octopamine	SLC6A3 SLC6A4	2.43e-04	8	68	2	ctd:D009655
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	LMAN1 PPFIBP2 PLEKHA6 ZZEF1 UTRN	2.68e-04	191	68	5	3975_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	SEMA4D LMAN1 ARHGAP33 PADI1 SENP5	2.68e-04	191	68	5	3803_DN
Drug	Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A	PLEKHA6 ZZEF1 UTRN ARHGAP33 PADI1	2.74e-04	192	68	5	2846_UP
Drug	Delcorine; Up 200; 8.4uM; PC3; HT_HG-U133A	ZSWIM8 SEMA3D LATS1 HKDC1 SENP5	2.74e-04	192	68	5	3715_UP
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	LMAN1 PPFIBP2 ELP1 NLE1 UTRN	2.88e-04	194	68	5	3321_DN
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	SEMA4D EGFR UTRN ARHGAP33 PADI1	2.88e-04	194	68	5	4455_DN
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; HL60; HT_HG-U133A	ARL1 LMAN1 INPP5D ARFGEF1 UTRN	2.88e-04	194	68	5	1293_UP
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A	LATS1 LMAN1 LPAR4 ELP1 PADI1	2.95e-04	195	68	5	3201_DN
Drug	AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A	EGFR KCNAB2 ELP1 UTRN SENP5	2.95e-04	195	68	5	6890_DN
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; HL60; HG-U133A	FBXO42 ARFGEF1 CPSF1 CNP MYBL2	3.02e-04	196	68	5	1770_DN
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EGFR LNPEP KCNAB2 PLEKHA6 UTRN	3.02e-04	196	68	5	3351_DN
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A	SEMA4D CADM1 ELP1 UTRN PADI1	3.02e-04	196	68	5	4597_UP
Drug	Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	LPAR4 EGFR ELP1 UTRN PADI1	3.02e-04	196	68	5	7333_UP
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A	ZSWIM8 CADM1 PPFIBP2 MBL2 CPSF1	3.02e-04	196	68	5	4075_UP
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A	EGFR FBXO42 NLE1 PADI1 SENP5	3.02e-04	196	68	5	5240_DN
Drug	Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A	ATR INPP5D FBXO42 BCORL1 CNP	3.09e-04	197	68	5	1718_UP
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A	SEMA4D LMAN1 EGFR PLEKHA6 ARHGAP33	3.09e-04	197	68	5	2277_DN
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	LATS1 LMAN1 PPFIBP2 ZZEF1 ARHGAP33	3.09e-04	197	68	5	3551_UP
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	SEMA4D ZSWIM8 ELP1 PLEKHA6 SENP5	3.09e-04	197	68	5	5527_DN
Drug	Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	ZSWIM8 EGFR KCNAB2 ZZEF1 UTRN	3.09e-04	197	68	5	6779_UP
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	LPAR4 TULP4 PPFIBP2 ELP1 ARHGAP33	3.09e-04	197	68	5	7360_UP
Drug	Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SEMA4D EGFR BCORL1 ELP1 SENP5	3.09e-04	197	68	5	5536_DN
Drug	Nefazodone	SLC6A3 SLC6A4	3.12e-04	9	68	2	DB01149
Drug	mephedrone	SLC6A3 SLC6A4	3.12e-04	9	68	2	ctd:C548233
Drug	phenethylamine	SLC6A3 SLC6A4	3.12e-04	9	68	2	ctd:C029261
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SEMA4D KCNAB2 ZZEF1 UTRN PADI1	3.16e-04	198	68	5	6001_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; HL60; HG-U133A	CADM1 LMAN1 FBXO42 NLE1 CNP	3.16e-04	198	68	5	1743_UP
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	TULP4 LNPEP KCNAB2 NLE1 UTRN	3.16e-04	198	68	5	6800_UP
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	LMAN1 ATR NLE1 PLEKHA6 UTRN	3.16e-04	198	68	5	2062_DN
Drug	Methocarbamol [532-03-6]; Up 200; 16.6uM; PC3; HT_HG-U133A	LMAN1 KCNAB2 CPSF1 ARHGAP33 SENP5	3.16e-04	198	68	5	2111_UP
Drug	iloprost; Up 200; 1uM; MCF7; HG-U133A	ZFAND1 ATR KCNAB2 ARHGAP33 PADI1	3.16e-04	198	68	5	488_UP
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; HL60; HG-U133A	BCORL1 LSP1 ACYP2 CNP PADI1	3.16e-04	198	68	5	1969_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	LMAN1 FBXO42 BCORL1 NLE1 PADI1	3.16e-04	198	68	5	1502_UP
Drug	Etodolac [41340-25-4]; Down 200; 14uM; HL60; HG-U133A	ARL1 LMAN1 BCORL1 KCNAB2 ARFGEF1	3.16e-04	198	68	5	1407_DN
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SEMA4D ZSWIM8 LNPEP BCORL1 ARFGEF1	3.24e-04	199	68	5	3357_DN
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	FBXO42 ARFGEF1 ELP1 PLEKHA6 UTRN	3.24e-04	199	68	5	3341_DN
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A	SEMA4D LATS1 CADM1 KCNAB2 ELP1	3.24e-04	199	68	5	5048_DN
Disease	Parkinsonism (biomarker_via_orthology)	SLC6A3 SLC6A4 EGFR	6.09e-05	34	66	3	DOID:0080855 (biomarker_via_orthology)
Disease	Memory Loss	SLC6A3 SLC6A4 LNPEP	1.24e-04	43	66	3	C0751295
Disease	Age-Related Memory Disorders	SLC6A3 SLC6A4 LNPEP	1.24e-04	43	66	3	C0751292
Disease	Memory Disorder, Spatial	SLC6A3 SLC6A4 LNPEP	1.24e-04	43	66	3	C0751294
Disease	Memory Disorder, Semantic	SLC6A3 SLC6A4 LNPEP	1.24e-04	43	66	3	C0751293
Disease	Memory Disorders	SLC6A3 SLC6A4 LNPEP	1.24e-04	43	66	3	C0025261
Disease	Memory impairment	SLC6A3 SLC6A4 LNPEP	1.33e-04	44	66	3	C0233794
Disease	asthma (is_implicated_in)	SLC6A4 MBL2 NPSR1 ELP1	4.30e-04	157	66	4	DOID:2841 (is_implicated_in)
Disease	Alcohol abuse	SLC6A3 SLC6A4 EGFR	4.62e-04	67	66	3	C0085762
Disease	employment status	ARHGAP15 MBL2	5.08e-04	15	66	2	EFO_0005241
Disease	Congenital Intestinal Aganglionosis	SEMA3D SEMA3C	6.56e-04	17	66	2	C3661523
Disease	Malignant neoplasm of endometrium	ATR EGFR	7.37e-04	18	66	2	C0007103
Disease	Carcinoma in situ of endometrium	ATR EGFR	7.37e-04	18	66	2	C0346191
Disease	inflammatory bowel disease (is_implicated_in)	EGFR NPSR1	8.22e-04	19	66	2	DOID:0050589 (is_implicated_in)
Disease	attention deficit hyperactivity disorder (is_implicated_in)	SLC6A3 SLC6A4	9.12e-04	20	66	2	DOID:1094 (is_implicated_in)
Disease	CCL24 measurement	SEMA3C VDAC2	1.11e-03	22	66	2	EFO_0009418
Disease	Adenocarcinoma of lung (disorder)	LATS1 ATR EGFR CMTR2	1.19e-03	206	66	4	C0152013
Disease	Anhedonia	SLC6A3 SLC6A4	1.32e-03	24	66	2	C0178417
Disease	breast carcinoma (is_implicated_in)	CADM1 EGFR	1.43e-03	25	66	2	DOID:3459 (is_implicated_in)
Disease	Adenoid Cystic Carcinoma	BCORL1 MGA CMTR2	1.48e-03	100	66	3	C0010606
Disease	bipolar disorder (is_implicated_in)	SLC6A4 MBL2	1.92e-03	29	66	2	DOID:3312 (is_implicated_in)
Disease	Marijuana Abuse	SLC6A4 EGFR	2.06e-03	30	66	2	C0024809
Disease	Hirschsprung Disease	SEMA3D SEMA3C	2.20e-03	31	66	2	C0019569

Protein segments in the cluster

Peptide	Gene	Start	Entry
ARKIGVVGWVKNTSK	ACYP2	31	P14621
KLNWTGTSKSGVQYK	AHSA1	86	O95433
EQRTALWKAGFKGKS	ARFGEF1	1701	Q9Y6D6
GKGRWSQQKTRSPKS	BCORL1	1436	Q5H9F3
KKSSIGCSTNTKWFG	CMTR2	421	Q8IYT2
RASWKKRSGSVIGKY	CRACR2A	401	Q9BSW2
RKWQIFKTSATKGTG	ARL1	151	P40616
WGLGTNSSESRKTKK	ATXN7L3	296	Q14CW9
TGKVKRSQGDKKTWR	PADI1	126	Q9ULC6
EKGRVKWKVFNSSSV	FBXO42	656	Q6P3S6
SRTGKTNDFTKIKGW	MGA	781	Q8IWI9
GNSVVLFSTWRRKKK	NPSR1	66	Q6W5P4
SVNRKQSWKGSKESL	LATS1	171	O95835
GFSKRVWKTYLSKIT	LPAR4	191	Q99677
KKRVDATAGWSAAGK	CPSF1	421	Q10570
GIGAKRSPSTSWFQK	KIAA0408	366	Q6ZU52
LKSQRGSVWTKTKAA	LMAN1	86	P49257
RIKKWLTFSLGKQVG	MBL2	121	P11226
TTVFKVGAKTDKGWS	LNPEP	861	Q9UIQ6
SKFITVGWGRKETQF	ELP1	156	O95163
VGRGLKKQWSTSSKS	PITPNM2	296	Q9BZ72
SSLVITTKIFWGGKA	KCNAB2	111	Q13303
KKFWGKIRRTQSGNF	PPFIBP2	501	Q8ND30
RAVLGVSSTQGKWKA	OR1S2	236	Q8NGQ3
EKQRKPGGSSWKTFF	ARHGAP33	581	O14559
TIRWFKGNTELKGKS	CADM1	176	Q9BY67
NWKKLFGTSGQKTKI	EGFR	476	P00533
RYKSSQKSTDWSGVK	ATR	1461	Q13535
KWKRVKAGNANSKTG	GBX2	301	P52951
GTGKTSTLVKYAEKW	FBH1	466	Q8NFZ0
GWLTVSLRVGKYKKT	DHCR24	96	Q15392
GWFLTKKSSETLRKA	CNP	191	P09543
GTPFFSSKQGKKTWR	MCF2	446	P10911
LWEQKGGSKTSSTIK	LSP1	296	P33241
KVGSVVSVGWLRSKK	SLC20A1	626	Q8WUM9
KGKELTKVFSDGSTW	SACS	1971	Q9NZJ4
STKGKTDLSVQIWGK	RXYLT1	91	Q9Y2B1
SWRYKISVTLSGKEK	PNLIPRP2	356	P54317
SFDKSIKLWDGRTGK	NLE1	391	Q9NVX2
TFTKWINARFSKSGK	UTRN	36	P46939
GGLRSLVNKWTTFLK	SEMA3C	271	Q99985
GVLLSWTKKFKARGV	HKDC1	166	Q2TB90
WNSTIKRKVDTGGFL	MYBL2	176	P10244
LNWKTTVNYKGKGSA	ODAD2	371	Q5T2S8
IADGGKKLRKNWSTS	ARHGAP15	91	Q53QZ3
KITSWFLSKGQGKTR	INPP5D	421	Q92835
FQVFKTHKKGWGLRT	SETMAR	141	Q53H47
QGGLRTLQKKWTSFL	SEMA4D	261	Q92854
PGKQWKGQFTTVRKS	PRORP	331	O15091
GGQRSLINKWTTFLK	SEMA3D	291	O95025
VKYGWVVKSRTSFSK	ATG4D	76	Q86TL0
NQSQGSRKGWKSKRS	TULP4	1421	Q9NRJ4
TKAGWLFKQASSGVK	PLEKHA6	61	Q9Y2H5
FQKWTASNRTSGLGK	VIL1	346	P09327
TKGYNGVKRWTKKVD	SENP5	616	Q96HI0
SGQSKLKTFWKGFTI	TIGD1	366	Q96MW7
WKGVKTSGKVVWITA	SLC6A3	256	Q01959
TGLTKGEIKKWFSDT	ZHX1	501	Q9UKY1
DTGKVTGTLETKYKW	VDAC2	61	P45880
SKKWKSIFNLGRSGS	ARHGAP31	301	Q2M1Z3
TFWKRKKINSGSDRS	ZNF518A	326	Q6AHZ1
GKKNKVSTSRQTWVA	ZSWIM8	816	A7E2V4
KKCSKGTGFSKTWLL	ZZEF1	2386	O43149
SKTGETASKRWKGAK	ZFAND1	121	Q8TCF1
TASKRWKGAKNSETA	ZFAND1	126	Q8TCF1
QWAKTSGEKRGKLTL	ZSCAN29	616	Q8IWY8
WKGVKTSGKVVWVTA	SLC6A4	271	P31645
QGLAKFGRRWTKISK	MYSM1	131	Q5VVJ2
GLYTKGSTWKGKSTQ	NMNAT3	231	Q96T66